FOUR-YEAR INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION PATIENTS WITH OR AT HIGH RISK FOR ATHEROSCLEROSIS

被引：0
|
作者：
Miao, Benjamin
Baker, William
Hernandez, Adrian V.
Mangiafico, Nicholas
Alberts, Mark J.
Roman, Yuani
Coleman, Craig I.
机构：
[1] Hartford Hosp, Hartford, CT 06115 USA
[2] Univ Connecticut, Sch Pharm, Storrs, CT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1320-232
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [1] Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
    Miao, Benjamin
    Hernandez, Adrian V.
    Roman, Yuani M.
    Alberts, Mark J.
    Coleman, Craig I.
    Baker, William L.
    [J]. CLINICAL CARDIOLOGY, 2020, 43 (05) : 524 - 531
  • [2] Four-Year Incidence of Major Adverse Cardiovascular Events in Patients With Established Cerebrovascular Disease
    Miao, Benjamin
    Hernandez, Adrian
    Alberts, Mark
    Roman, Yuani
    Coleman, Craig
    [J]. STROKE, 2020, 51
  • [3] microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
    de los Reyes-Garcia, Ascension M.
    Zapata-Martinez, Laura
    Aguila, Sonia
    Lozano, Maria L.
    Martinez, Constantino
    Gonzalez-Conejero, Rocio
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [4] Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation
    Pignatelli, P.
    Pastori, D.
    Lip, G.
    Violi, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 392 - 392
  • [5] Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
    Cutler, Michael J.
    May, Heidi T.
    Bair, Tami L.
    Crandall, Brian G.
    Osborn, Jeffrey S.
    Miller, Jared D.
    Mallender, Charles D.
    Muhlestein, Joseph B.
    Anderson, Jeffrey L.
    Knowlton, Kirk U.
    Knight, Stacey
    [J]. IJC HEART & VASCULATURE, 2022, 43
  • [6] Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
    De Caterina, Raffaele
    Patti, Giuseppe
    Westerbergh, Johan
    Horowitz, John
    Ezekowitz, Justin A.
    Lewis, Basil S.
    Lopes, Renato D.
    McMurray, John J., V
    Atar, Dan
    Bahit, M. Cecilia
    Keltai, Matyas
    Lopez-Sendon, Jose L.
    Ruzyllo, Witold
    Granger, Christopher B.
    Alexander, John H.
    Wallentin, Lars
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (03) : 227 - 235
  • [7] ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
    Aten, Kristopher
    Wang, Lucas
    Hoang, Lawrence M.
    Abualfoul, Mujahed
    Canela, Victor
    Pravathida, Sri
    Vu, Michael
    Zhao, Yi
    Sidhu, Manavjot Singh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2158 - 2158
  • [8] Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
    Wang, Lucas
    Hoang, Lawrence
    Aten, Kristopher
    Abualfoul, Mujahed
    Canela, Victor
    Prathivada, Sri
    Vu, Michael
    Zhao, Yi
    Sidhu, Manavjot
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 41 - 48
  • [9] Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
    Wang, Lucas
    Hoang, Lawrence
    Aten, Kristopher
    Abualfoul, Mujahed
    Canela, Victor
    Prathivada, Sri
    Vu, Michael
    Zhao, Yi
    Sidhu, Manavjot
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 41 - 48
  • [10] Heartbeat: atrial fibrillation phenotyping identifies patients at high risk of adverse events
    Otto, Catherine M.
    [J]. HEART, 2023, 109 (23) : 1725 - 1726
12345